Investigator-sponsored study funded by Glaucoma UK and the HSC R&D Division expands ART27.13’s clinical potential into ophthalmologyFirst ...

Explore the latest research on glaucoma treatment and the role of immune cells in eye pressure regulation for better outcomes ...

Artelo Biosciences (NASDAQ:ARTL) is expanding its development pipeline into ophthalmology with a new clinical study evaluating its drug candidate ART27.13 for the treatment of glaucoma. The San ...

Add Yahoo as a preferred source to see more of our stories on Google. The scientists suggest that agmatine and thiamine could be used as biomarkers for earlier detection of glaucoma, allowing doctors ...

Glaucoma develops when fluid inside the eye doesn’t drain properly, causing pressure to build up over time and damage the ...

New York City, New York (CBS) - Glaucoma is one of the leading causes of blindness in the U.S. And doctors are stressing why it’s so important to get tested and treated early for the disease.

AI could revolutionise glaucoma detection. Here’s 6 things everyone should know - Age and family history are significant risk ...

Glaucoma Research Foundation (GRF) today announced a new partnership with Alcon, the global leader in eye care, to expand access to trusted, patient-centered glaucoma education for Spanish-speaking ...

Explore the silent thief of sight: glaucoma. This article sheds light on the urgent need for awareness and action to prevent ...